These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 8691467

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Novel technetium-99m-labeled platelet GPIIb/IIIa receptor antagonists as potential imaging agents for venous and arterial thrombosis.
    Mousa SA, Bozarth JM, Edwards S, Carroll T, Barrett J.
    Coron Artery Dis; 1998; 9(2-3):131-41. PubMed ID: 9647415
    [Abstract] [Full Text] [Related]

  • 4. Thrombus imaging with a technetium-99m-labeled activated platelet receptor-binding peptide.
    Lister-James J, Knight LC, Maurer AH, Bush LR, Moyer BR, Dean RT.
    J Nucl Med; 1996 May; 37(5):775-81. PubMed ID: 8965144
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Preparation and characterization of [99TcO] apcitide: a technetium labeled peptide.
    Francesconi LC, Zheng Y, Bartis J, Blumenstein M, Costello C, De Rosch MA.
    Inorg Chem; 2004 May 03; 43(9):2867-75. PubMed ID: 15106974
    [Abstract] [Full Text] [Related]

  • 7. Antithrombotic properties of L-cysteine, N-(mercaptoacetyl)-D-Tyr-Arg-Gly-Asp-sulfoxide (G4120) in a hamster platelet-rich femoral vein thrombosis model.
    Imura Y, Stassen JM, Bunting S, Stockmans F, Collen D.
    Blood; 1992 Sep 01; 80(5):1247-53. PubMed ID: 1515641
    [Abstract] [Full Text] [Related]

  • 8. A three-residue cyclic scaffold of non-RGD containing peptide analogues as platelet aggregation inhibitors: design, synthesis, and structure--function relationships.
    Stavrakoudis A, Bizos G, Eleftheriadis D, Kouki A, Panou-Pomonis E, Sakarellos-Daitsiotis M, Sakarellos C, Tsoukatos D, Tsikaris V.
    Biopolymers; 1992 Sep 01; 56(1):20-6. PubMed ID: 11582574
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Biological evaluation of thrombus imaging agents utilizing water soluble phosphines and tricine as coligands when used to label a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTc.
    Barrett JA, Crocker AC, Damphousse DJ, Heminway SJ, Liu S, Edwards DS, Lazewatsky JL, Kagan M, Mazaika TJ, Carroll TR.
    Bioconjug Chem; 1997 Sep 01; 8(2):155-60. PubMed ID: 9095355
    [Abstract] [Full Text] [Related]

  • 11. Biological evaluation of 99mTc-labeled cyclic glycoprotein IIb/IIIa receptor antagonists in the canine arteriovenous shunt and deep vein thrombosis models: effects of chelators on biological properties of [99mTc]chelator-peptide conjugates.
    Barrett JA, Damphousse DJ, Heminway SJ, Liu S, Edwards DS, Looby RJ, Carroll TR.
    Bioconjug Chem; 1996 Sep 01; 7(2):203-8. PubMed ID: 8983342
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of integrin-mediated platelet aggregation, fibrinogen-binding, and interactions with extracellular matrix by nonpeptidic mimetics of Arg-Gly-Asp.
    Varon D, Lider O, Dardik R, Shenkman B, Alon R, Hershkoviz R, Kapustina G, Savion N, Martinowitz U, Greenspoon N.
    Thromb Haemost; 1993 Dec 20; 70(6):1030-6. PubMed ID: 8165596
    [Abstract] [Full Text] [Related]

  • 13. The application of tetrahydroisoquinoline-3-carbonyl-TARGD(F)F as an anti-thrombotic agent having dual mechanisms of action.
    Yang G, Zhu H, Zhao M, Wu J, Wang Y, Wang Y, Zheng M, Chen M, Liu J, Peng S.
    Mol Biosyst; 2012 Oct 20; 8(10):2672-9. PubMed ID: 22801714
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. New and versatile ternary ligand system for technetium radiopharmaceuticals: water soluble phosphines and tricine as coligands in labeling a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTc.
    Edwards DS, Liu S, Barrett JA, Harris AR, Looby RJ, Ziegler MC, Heminway SJ, Carroll TR.
    Bioconjug Chem; 1997 Oct 20; 8(2):146-54. PubMed ID: 9095354
    [Abstract] [Full Text] [Related]

  • 16. Development of a small RGD peptide fibrinogen receptor antagonist with potent antiaggregatory activity in vitro.
    Samanen J, Ali F, Romoff T, Calvo R, Sorenson E, Vasko J, Storer B, Berry D, Bennett D, Strohsacker M.
    J Med Chem; 1991 Oct 20; 34(10):3114-25. PubMed ID: 1920361
    [Abstract] [Full Text] [Related]

  • 17. Design and synthesis of novel cyclic RGD-containing peptides as highly potent and selective integrin alpha IIb beta 3 antagonists.
    Cheng S, Craig WS, Mullen D, Tschopp JF, Dixon D, Pierschbacher MD.
    J Med Chem; 1994 Jan 07; 37(1):1-8. PubMed ID: 7507165
    [Abstract] [Full Text] [Related]

  • 18. Design of potent and specific integrin antagonists. Peptide antagonists with high specificity for glycoprotein IIb-IIIa.
    Scarborough RM, Naughton MA, Teng W, Rose JW, Phillips DR, Nannizzi L, Arfsten A, Campbell AM, Charo IF.
    J Biol Chem; 1993 Jan 15; 268(2):1066-73. PubMed ID: 8419315
    [Abstract] [Full Text] [Related]

  • 19. Non-peptide RGD surrogates which mimic a Gly-Asp beta-turn: potent antagonists of platelet glycoprotein IIb-IIIa.
    Fisher MJ, Gunn B, Harms CS, Kline AD, Mullaney JT, Nunes A, Scarborough RM, Arfsten AE, Skelton MA, Um SL, Utterback BG, Jakubowski JA.
    J Med Chem; 1997 Jun 20; 40(13):2085-101. PubMed ID: 9207949
    [Abstract] [Full Text] [Related]

  • 20. Detection of deep venous thrombosis by DMP 444, a platelet IIb/IIIa antagonist: a preliminary report.
    Klem JA, Schaffer JV, Crane PD, Barrett JA, Henry GA, Canestri L, Ezekowitz MD.
    J Nucl Cardiol; 2000 Jun 20; 7(4):359-64. PubMed ID: 10958278
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.